Aaron  Lesher  to  Immunotherapy, Adoptive
                            
                            
                                This is a "connection" page, showing publications  Aaron  Lesher  has written about  Immunotherapy, Adoptive.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.076
         
        
        
     
 
    
        
        - 
            CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. Cancer Immunol Immunother. 2010 Jun; 59(6):851-62.
            
            
                Score: 0.076